Primus Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PRIMUS PHARMS, and what generic alternatives to PRIMUS PHARMS drugs are available?
PRIMUS PHARMS has three approved drugs.
There are eleven US patents protecting PRIMUS PHARMS drugs.
There are twenty-five patent family members on PRIMUS PHARMS drugs in sixteen countries.
Summary for Primus Pharms
| International Patents: | 25 |
| US Patents: | 11 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Primus Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primus Pharms | SERNIVO | betamethasone dipropionate | SPRAY;TOPICAL | 208079-001 | Feb 5, 2016 | RX | Yes | Yes | 9,364,485 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | 9,855,334 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Primus Pharms | SERNIVO | betamethasone dipropionate | SPRAY;TOPICAL | 208079-001 | Feb 5, 2016 | RX | Yes | Yes | 9,775,851 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | 10,064,875 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Primus Pharms | SERNIVO | betamethasone dipropionate | SPRAY;TOPICAL | 208079-001 | Feb 5, 2016 | RX | Yes | Yes | 9,877,974 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Primus Pharms | SERNIVO | betamethasone dipropionate | SPRAY;TOPICAL | 208079-001 | Feb 5, 2016 | RX | Yes | Yes | 10,179,137 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | 10,588,914 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for PRIMUS PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.05% | ➤ Subscribe | 2018-02-15 |
International Patents for Primus Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20200051854 | ⤷ Try a Trial |
| China | 107872972 | ⤷ Try a Trial |
| European Patent Office | 3267978 | ⤷ Try a Trial |
| European Patent Office | 2473161 | ⤷ Try a Trial |
| South Korea | 20170123335 | ⤷ Try a Trial |
| Brazil | 112017019352 | ⤷ Try a Trial |
| Canada | 2979051 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
